Forum Alert: BioSante Pharmaceuticals, Inc. Presentation at
Informed Investors Biotechnology & Pharmaceuticals Stocks Forum at the
Princeton Club in NYC on Wednesday, June 23, 2004, 1:30 pm ET
LINCOLNSHIRE, Ill., June 18 /PRNewswire/ -- Stephen Simes, President & Chief
Executive Officer of BioSante Pharmaceuticals, Inc. (AMEX:BPA), will present at
the following forum: What: Informed Investors Biotechnology & Pharmaceuticals Stocks Forum When: June 23, 2004 @ 1:30 PM Eastern Time Where: The Princeton Club of New York, 15 West 43rd St. (Between 5th and
6th Avenues) New York, NY 10036 How: To attend live event, pre-registration is necessary. To register
contact Cary Loeser, , 804-327-3407 or call
Customer Service at 888-301-6618 If you are unable to attend the live event, the forum will be available via
webcast at
http://www.informedinvestors.com/CustomEvent/85117/index.asp?ForumID=85117.
BioSante is developing a pipeline of hormone therapy products to treat both men
and women. BioSante's hormone therapy products are gel formulations for
transdermal administration that deliver bioidentical estradiol and
testosterone. Symptoms treated with hormone therapy in men include impotence,
diminished sex drive, muscle weakness and osteoporosis. Symptoms in menopausal
women include hot flashes, vaginal atrophy, decreased libido and osteoporosis.
The estrogen and testosterone markets in the United States alone account for
over $2.5 billion in annual sales.
The company also is developing its calcium phosphate nanotechnology (CAP) for
novel vaccines, including biodefense vaccines for toxins such as anthrax and
ricin, and drug delivery systems. Additional information is available online
at http://www.biosantepharma.com/.
FORUM CONTACT: Cary Loeser, Informed Investors, 804-327-3407, Web site: http://www.informedinvestors.com DATASOURCE: BioSante Pharmaceuticals, Inc.
CONTACT: Cary Loeser of Informed Investors, +1-804-327-3407 or Web site: http://www.informedinvestors.com/ http://www.biosantepharma.com/
|